Skip to main content
COSM
NASDAQ Life Sciences

NOOR 胶原蛋白美国收入预计超过1200万美元,用于Cosmos Health;公司报告创纪录的势头,无中东冲突影响

feedReported by Access Newswire
Sentiment info
Positive
Importance info
9
Price
$0.288
Mkt Cap
$10.781M
52W Low
$0.28
52W High
$1.32
Market data snapshot near publication time

summarizeSummary

Cosmos Health宣布,其NOOR 胶原蛋白产品预计在未来12个月内在美国产生超过1200万美元的收入,预计毛利率约为75%。该公司还报告了持续的创纪录收入势头,2025年第三季度收入达到创纪录的1710万美元,同比增长38%,并确认正在进行的中东冲突对其运营没有重大影响。这种单一产品的重大收入预测,特别是对于一家市值约为1000万美元的公司来说,代表着一个实质性的增长催化剂,并提供了强有力的前瞻指引。这个消息是在最近的C-Scrub Wash和Liv18产品开发公告之后,这表明业务正在积极扩张。投资者将会关注即将发布的2025年第四季度和全年财务结果,以获取更详细的财务信息和确认这一势头。

在该公告发布时,COSM的交易价格为$0.29,交易所为NASDAQ,所属行业为Life Sciences,市值约为$1078.1万。 52周交易区间为$0.28至$1.32。 这则新闻被评估为积极市场情绪,重要性评分为9/10。 来源:Access Newswire。


show_chartPrice Chart

Share this article

Copied!

feed COSM - Latest Insights

COSM
Apr 24, 2026, 4:30 PM EDT
Filing Type: S-3/A
Importance Score:
9
COSM
Apr 20, 2026, 10:55 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 17, 2026, 2:00 PM EDT
Source: Access Newswire
Importance Score:
7
COSM
Apr 15, 2026, 4:34 PM EDT
Filing Type: 10-K
Importance Score:
9
COSM
Apr 15, 2026, 9:25 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 13, 2026, 12:50 PM EDT
Source: Access Newswire
Importance Score:
7
COSM
Apr 10, 2026, 9:40 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 08, 2026, 11:10 AM EDT
Source: Access Newswire
Importance Score:
8
COSM
Apr 01, 2026, 11:42 AM EDT
Source: Access Newswire
Importance Score:
7
COSM
Mar 19, 2026, 12:45 PM EDT
Source: GlobeNewswire
Importance Score:
9